International Journal of Cancer Management

Published by: Kowsar

Clinicopathology Figures and Survival of Non-Hodgkin’s Lymphoma in Iran

Safa Najafi 1 , Mehrdad Payandeh 2 and Masoud Sadeghi 2 , *
Authors Information
1 Breast Diseases Department, Breast Cancer Research Centre, ACECR, Iran
2 Cancer Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Article information
  • Iranian Journal of Cancer Prevention: January 2017, 10 (1); e5226
  • Published Online: January 21, 2017
  • Article Type: Research Article
  • Received: January 1, 2016
  • Revised: February 22, 2016
  • Accepted: January 3, 2017
  • DOI: 10.17795/ijcp-5226

To Cite: Najafi S, Payandeh M, Sadeghi M. Clinicopathology Figures and Survival of Non-Hodgkin’s Lymphoma in Iran, Int J Cancer Manag. 2017 ;10(1):e5226. doi: 10.17795/ijcp-5226.

Abstract
© 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Memar B, Aledavood A, Shahidsales S, Ahadi M, Farzadnia M, Raziee HR, et al. The Prognostic Role of Tumor Marker CA-125 in B-Cell non-Hodgkin's Lymphoma. Iran J Cancer Prev. 2015; 8(1): 42-6[PubMed]
  • 2. Aminian O, Abedi A, Chavoshi F, Ghasemi M, Rahmati-Najarkolaei F. Evaluation of Occupational Risk Factors in Non-Hodgkin Lymphoma and Hodgkin's Disease in Iranian Men. Iran J Cancer Prev. 2012; 5(4): 189-93[PubMed]
  • 3. Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007; 120 Suppl 12: 1-39[DOI][PubMed]
  • 4. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005; 84(1): 1-12[DOI][PubMed]
  • 5. Ansell SM, Armitage J. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc. 2005; 80(8): 1087-97[DOI][PubMed]
  • 6. Hashemi-Bahremani M, Parwaresch MR, Tabrizchi H, Gupta RK, Raffii MR. Lymphomas in Iran. Arch Iran Med. 2007; 10(3): 343-8[PubMed]
  • 7. Broyde A, Boycov O, Strenov Y, Okon E, Shpilberg O, Bairey O. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Am J Hematol. 2009; 84(6): 338-43[DOI][PubMed]
  • 8. Hosseini S, Dehghan P. Primary non-hodgkin lymphoma of the stomach: clinicopathological characteristics and prognostic factors in Iranian patients. Iran J Cancer Prev. 2014; 7(4): 219-24[PubMed]
  • 9. Kahl B. Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma. Semin Hematol. 2008; 45(2): 90-4[DOI][PubMed]
  • 10. Newton R, Ferlay J, Beral V, Devesa SS. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer. 1997; 72(6): 923-30[PubMed]
  • 11. Irshaid F, Tarawneh K, Alshdefat A, Dilmi F, Jaran A, Al-Hadithi R, et al. Loss of P16 Protein Expression and Its Association with Epstein-Barr Virus LMP-1 Expression in Hodgkin's Lymphoma. Iran J Cancer Prev. 2013; 6(2): 78-84[PubMed]
  • 12. Aledavood SA, Ghavam-Nasiri MR, Ghaffarzadegan K, Raziee HR, Saboori G, Anvari K, et al. Hepatitis-C Infection Incidence Among the non-Hodgkin's B-cell Lymphoma Patients in the Northeast of Iran. Iran J Cancer Prev. 2014; 7(3): 147-51[PubMed]
  • 13. Barbieri E, Cammelli S, Mauro F, Perini F, Cazzola A, Neri S, et al. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II. Int J Radiat Oncol Biol Phys. 2004; 59(3): 760-4[DOI][PubMed]
  • 14. Economopoulos T, Asprou N, Stathakis N, Fountzilas G, Pavlidis N, Papaspyrou S, et al. Primary extranodal non-Hodgkin's lymphoma of the head and neck. Oncology. 1992; 49(6): 484-8[PubMed]
  • 15. Naz E, Mirza T, Aziz S, Danish F, Siddiqui ST, Ali A. Frequency and clinicopathologic correlation of different types of non Hodgkin's lymphoma according to WHO classification. J Pak Med Assoc. 2011; 61(3): 260-3[PubMed]
  • 16. Padhi S, Paul TR, Challa S, Prayaga AK, Rajappa S, Raghunadharao D, et al. Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis. Asian Pac J Cancer Prev. 2012; 13(10): 4889-95[PubMed]
  • 17. Otter R, Gerrits WB, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol. 1989; 25(8): 1203-10[PubMed]
  • 18. Payandeh M, Sadeghi M, Sadeghi E. The ki-67 index in non-hodgkin's lymphoma: Role and prognostic significance. American J Cancer Prevention. 2015; 3(5): 100-2
  • 19. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, et al. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Ai Zheng. 2006; 25(12): 1543-9[PubMed]
  • 20. Friedberg JW, Fisher RI. Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am. 2008; 22(5): 941-52[DOI][PubMed]
  • 21. Hauptrock B, Hess G. Rituximab in the treatment of non-Hodgkin's lymphoma. Biologics. 2008; 2(4): 619-33[PubMed]
  • 22. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(4): 235-42[DOI][PubMed]
  • 23. Sengar M, Akhade A, Nair R, Menon H, Shet T, Gujral S, et al. A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center. Indian J Med Paediatr Oncol. 2011; 32(4): 197-203[DOI][PubMed]
  • 24. Payandeh M, Sadeghi M, Shahriari-Ahmadi A, Sadeghi E. The survival of nodal non-hodgkin's lymphoma patients in the west of Iran. American J Cancer Prevention. 2015; 3(5): 103-5
  • 25. Payandeh M, Sadeghi M, Sadeghi E, Aeinfar M. The survival of extra nodal non-hodgkin's lymphoma patients in the west of Iran. American J Cancer Prevention. 2015; 3(5): 96-9

Altmetric:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Comments